| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 119.3× | −1.7× | |
| Price / Book | −156.2× | 2.0× | |
| Price / Sales | 8.2× | 3.9× | |
| Price / Free cash flow | 28.3× | −1.6× | |
| EV / EBITDA | 32.2× | −1.2× | |
| Earnings yield | 0.8% | −14.6% | |
| Free cash flow yield | 3.5% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,248.25 | −0.70% | $1.18T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $253.61 | −0.76% | $611.17B | 23.0× | 32.9% | +33.7% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $402.31 | +0.22% | $361.11B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.54 | −0.97% | $356.6B | 19.7× | 34.7% | +73.5% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.38 | −0.16% | $278.19B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $165.15 | −0.16% | $256.13B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $676.28 | −1.99% | $250.05B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $427.96 | −1.05% | $231.37B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $154.45 | −1.11% | $191.51B | 22.8× | 37.5% | +32.0% |
ABNYSE:ABTAbbott Laboratories · 🇺🇸 NYSE | $103.76 | −1.08% | $180.73B | 28.0× | 12.5% | −19.0% |
